Lanean...
Targeting the PI3K/AKT/mTOR/NFκB Axis in Ovarian Cancer
Ovarian cancer stands as the most lethal gynecologic malignancy and remains the fifth most common gynecologic cancer. Poor prognosis and low five-year survival rate are attributed to nonspecific symptoms at early phases along with a lack of effective treatment at advanced stages. It is thus paramoun...
Gorde:
| Argitaratua izan da: | J Cell Immunol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213295/ https://ncbi.nlm.nih.gov/pubmed/32395722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.33696/immunology.1.022 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|